MedPath

Ayurvedic Management of Paralysis in Children

Phase 2/3
Completed
Conditions
Spastic quadriplegic cerebral palsy,
Registration Number
CTRI/2019/06/019645
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Cerebral palsy is defined as a non-progressive neuromotor disorder of cerebral origin caused by insult or injury to developing brain during its early stage of development . Children affected with the disease present with developmental delay and motor deficits and may have one or more associated problem like mental retardation, seizures, feeding difficulties along with ophthalmologic and hearing impairments. Cerebral Palsy is most common motor disability affecting a large Pediatric population world-wide [2]. According to WHO(World Health Organization) estimation 10% of population has some form of disability due to different causes, in India it is 3.8% of population).Nearly 15-20% of total physical handicapped children are suffering from C.P. World- wide incidence of C.P is 2.5/1000 live births[4] and for India it is 3/1000 live births more than 15 million people worldwide and more than 25 lakh people in India are living with this disability.

For CP, there is no any direct reference in Ayurvedic classics.Some conditions are found discrete in classics at different,places like Phakka, Pangulya, Mukatva, Jadatva, Ekanga roga, Sarvanga roga, Pakshaghata, Pakshavadha etc. under the group of Vata Vyadhi which can be compared with the presentation of Cerebral palsy.If Vata is considered as major contributing factor for CP then Vata pacifying measures becomes essential component in the treatment. Treatment of Vata Dosha consists of a variety of treatment modalities like Abhyanga, Swedana and Basti.The total sample size for this clinical trial is required to be 30(15 in each group).The trial will be of 3 months~=Total 3 course of treatment, with an interval of 15

days between each course,One course of treatment will be for 17days [Udvaratana – 3 days Sarvanga Abhyanga and Bashpa swedana -14 days, Matra basti -7days(8thday of Sarvanga Abhyanga and Bashpa Swedana) and oral medicine with Balapanchamrita Yoga]. Group A (Abhayanga and Matra Basti with Ksheerabala Taila and Bashpa Swedana with Eranda Patra Kwatha with Internal Medication Balapanchamrita Yoga) and Group B (Abhyanga and Matra Basti with Murcchita

Tila Taila and Bashpa Swedana with simple water steam with Internal Medication Balapanchamrita Yoga)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Age group of 1 to 12 years of either gender Diagnosed Case of Cerebral palsy Parents submitting written consent to participate in the study.

Exclusion Criteria

Progressive neurological disorder,Children suffering from any systemic illness,Children with severe intractable epilepsy as co-morbidity,Acute illness that would interfere with carrying out the interventions, Recent orthopedic surgery/casting/splint,Children had received botox (last 1yr) or had undergone phenol block injection or intrathecal baclofen medication,Fixed contractures, Congenital disorders like Down’s syndrome, Fragile -X syndrome or any congenital anomalies,Caregiver not willing to sign the informed consent form.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response in spasticity and range of motion (ROM) of joints.assessment will be made on before treatment and after treatment | [After 02 months of Follow up]
Expected outcome will be 17.5%.assessment will be made on before treatment and after treatment | [After 02 months of Follow up]
Secondary Outcome Measures
NameTimeMethod
Response in the quality of life (QOL)90 days

Trial Locations

Locations (1)

All India Institute of Ayurveda sarita vihar

🇮🇳

Delhi, DELHI, India

All India Institute of Ayurveda sarita vihar
🇮🇳Delhi, DELHI, India
Upasana sonker
Principal investigator
8851363937
drupasanasonker23@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.